review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Jay B Wish | |
P921 | main subject | iron | Q677 |
P304 | page(s) | S4-8 | |
P577 | publication date | 2006-09-01 | |
P1433 | published in | Clinical Journal of the American Society of Nephrology | Q15757929 |
P1476 | title | Assessing iron status: beyond serum ferritin and transferrin saturation | |
P478 | volume | 1 Suppl 1 |
Q35998091 | A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients. |
Q42285098 | Absolute and Functional Iron Deficiency Anemia among Different Tumors in Cancer Patients in South Part of Iran, 2014 |
Q57175195 | Adverse Outcome Prediction of Iron Deficiency in Patients with Acute Coronary Syndrome |
Q43923945 | Anaemia and iron deficiency in heart failure: epidemiological gaps, diagnostic challenges and therapeutic barriers in sub-Saharan Africa |
Q42293553 | Anaemia in inflammatory bowel disease |
Q28069820 | Anemia and iron deficiency in gastrointestinal and liver conditions |
Q37737810 | Anemia and transfusions in geriatric patients: a time for evaluation |
Q34782520 | Antioxidant status, C-reactive protein and iron status in patients with pulmonary tuberculosis. |
Q37627538 | Assessing the Association between Serum Ferritin, Transferrin Saturation, and C-Reactive Protein in Northern Territory Indigenous Australian Patients with High Serum Ferritin on Maintenance Haemodialysis |
Q42112719 | Association between neutrophil geletinase-associated lipocalin and iron deficiency anemia in children on chronic dialysis. |
Q34564073 | Association of anaemia in primary care patients with chronic kidney disease: cross sectional study of quality improvement in chronic kidney disease (QICKD) trial data |
Q58748590 | Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease |
Q37462055 | Association of hepcidin-25 with survival after kidney transplantation. |
Q38170331 | Association of iron indices and type 2 diabetes: a meta-analysis of observational studies |
Q37389742 | Associations between Lifestyle Factors and Iron Overload in Korean Adults. |
Q64968719 | Associations of genetically determined iron status across the phenome: A mendelian randomization study. |
Q37776267 | Automated reticulocyte counting: state of the art and clinical applications in the evaluation of erythropoiesis |
Q34169748 | Biological and clinical aspects of soluble transferrin receptor |
Q42182081 | Biomarkers of hypochromia: the contemporary assessment of iron status and erythropoiesis |
Q35012284 | Blood transfusion, serum ferritin, and iron in hemodialysis patients in Africa |
Q33684085 | Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease? |
Q36431188 | Changes in Mineral Micronutrient Status During and After Pulmonary Exacerbation in Adults With Cystic Fibrosis |
Q35244441 | Comment on: Evaluation of erythrocyte and reticulocyte parameters as indicative of iron deficiency in patients with anemia of chronic disease |
Q86906439 | Comparison of reticulocyte hemoglobin equivalent with traditional markers of iron and erythropoiesis in pediatric dialysis |
Q95271262 | Correlates of Nonanemic Iron Deficiency in Restless Legs Syndrome |
Q39019386 | Current evaluation and management of anemia in patients with inflammatory bowel disease |
Q38151564 | Current management of iron deficiency anemia in inflammatory bowel diseases: a practical guide |
Q36302219 | Decisive indicator for gastrointestinal workup in anemic patients with nondialysis chronic kidney disease |
Q36349371 | Deranged iron status in psoriasis: the impact of low body mass. |
Q91235641 | Detection of iron deficiency in children with Down syndrome |
Q39192941 | Diagnosing and preventing iron overload |
Q37937176 | Diagnosing anemia in inflammatory bowel disease: beyond the established markers |
Q34141999 | Diagnosis and management of iron deficiency anemia in patients with IBD. |
Q35018420 | Diagnosis and management of iron deficiency anemia in the 21st century |
Q38058415 | Diagnosis of anaemia: old things rearranged |
Q43137967 | Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia |
Q50266795 | Effect of intravenous iron on outcomes of acute kidney injury |
Q46083931 | Effect of iron supplementation during lactation on maternal iron status and oxidative stress: A randomized controlled trial |
Q91924358 | Effects of Genetically Determined Iron Status on Risk of Venous Thromboembolism and Carotid Atherosclerotic Disease: A Mendelian Randomization Study |
Q87820193 | Effects of additional iron doses on hepcidin-25 level in hemodialysis patients without evident iron deficiency |
Q50570321 | Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. |
Q51753810 | Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: a meta-analysis. |
Q37403306 | Erythropoietin stimulating agents in the management of anemia of chronic kidney disease |
Q86102619 | Evaluating plasma pharmacokinetics of intravenous iron formulations: judging books by their covers? |
Q33658410 | Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective |
Q92682745 | Evaluation of Iron Status in Patients of Chronic Kidney Disease - A Study to Assess the Best Indicators Including Serum Transferrin Receptor Assay |
Q28538067 | Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women--PREFER a randomized, placebo-controlled study |
Q36841741 | Ferritin Levels in Colombian Children: Findings from the 2010 National Nutrition Survey (ENSIN) |
Q24642942 | Ferritin for the clinician |
Q47994810 | Ferroportin in monocytes of hemodialysis patients and its associations with hepcidin, inflammation, markers of iron status and resistance to erythropoietin |
Q41474865 | Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells |
Q38657755 | Genetically encoded iron-associated proteins as MRI reporters for molecular and cellular imaging |
Q42276038 | HWA: Hypoferritinemia without anemia a hidden hematology disorder |
Q43798489 | Hematological variables and iron status in abdominoplasty after bariatric surgery |
Q36366398 | Hemoglobin and plasma vitamin C levels in patients on peritoneal dialysis |
Q41825275 | Hemoglobin level as a risk factor for lower respiratory tract infections in Lebanese children |
Q37211057 | Hepcidin--a potential novel biomarker for iron status in chronic kidney disease |
Q28727076 | Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents |
Q47156054 | High Neonatal Blood Iron Content Is Associated with the Risk of Childhood Type 1 Diabetes Mellitus. |
Q101041624 | High Soluble Transferrin Receptor in Patients With Heart Failure: a Measure of Iron Deficiency And a Strong Predictor of Mortality |
Q52949564 | High pre-transplant serum ferritin and busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive syndrome after autologous stem cell transplantation in patients with malignant lymphoma. |
Q55287039 | Implementation of a patient blood management program in an Australian private hospital orthopedic unit. |
Q36552989 | Increased Body Mass Index may lead to Hyperferritinemia Irrespective of Body Iron Stores |
Q89127050 | Increased NGAL level associated with iron store in chronic kidney disease with anemia |
Q92446436 | Intravenous iron therapy in heart failure: a different perspective |
Q47102798 | Intravenous iron therapy in patients with chronic kidney disease: recent evidence and future directions |
Q84250704 | Intravenous iron therapy is the option for RA patient with absolute iron deficiency accompanied with functional iron deficiency |
Q57170016 | Intrinsic Iron Release Is Associated with Lower Mortality in Patients with Stable Coronary Artery Disease-First Report on the Prospective Relevance of Intrinsic Iron Release |
Q89636084 | Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment |
Q90667866 | Iron Status and Risk of Stroke |
Q33700880 | Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners |
Q90672995 | Iron and Heart Failure: Diagnosis, Therapies, and Future Directions |
Q42180857 | Iron as the key modulator of hepcidin expression in erythroid antibody-mediated hypoplasia |
Q39371536 | Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management |
Q38551016 | Iron deficiency and cardiovascular disease |
Q36682182 | Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives |
Q47708845 | Iron deficiency and red cell indices in patients with heart failure |
Q54380664 | Iron deficiency and risk of early readmission following a hospitalization for acute heart failure. |
Q40573772 | Iron deficiency anemia and megaloblastic anemia in obese patients. |
Q33822956 | Iron deficiency anemia in chronic liver disease: etiopathogenesis, diagnosis and treatment |
Q48716818 | Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure |
Q51114270 | Iron deficiency in a multi-ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis |
Q56968591 | Iron deficiency in chronic heart failure: case-based practical guidance |
Q38384454 | Iron deficiency in early pregnancy using serum ferritin and soluble transferrin receptor concentrations are associated with pregnancy and birth outcomes |
Q27023196 | Iron deficiency in gastrointestinal oncology |
Q38142571 | Iron deficiency in heart failure: a practical guide |
Q99365535 | Iron deficiency markers in patients undergoing iron replacement therapy: a 9-year retrospective real-world evidence study using healthcare databases |
Q36619022 | Iron deficient erythropoiesis might play key role in development of anemia in cancer patients |
Q49103122 | Iron isotopic composition of blood serum in anemia of chronic kidney disease |
Q36371665 | Iron metabolism and iron supplementation in cancer patients |
Q37992243 | Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis |
Q37331361 | Iron status and survival in diabetic patients with coronary artery disease |
Q36971596 | Iron status in patients with chronic heart failure |
Q51025555 | Iron supplementation prevents a decline in iron stores and enhances strength performance in elite female volleyball players during the competitive season. |
Q38264186 | Is iron treatment beneficial in, iron-deficient but non-anaemic (IDNA) endurance athletes? A systematic review and meta-analysis |
Q47943865 | Is it time for hepcidin to join the diagnostic toolkit for iron deficiency? |
Q50998053 | Long-Term Trends in Hematological and Nutritional Status After Gastrectomy for Gastric Cancer. |
Q51032568 | Long-term stability of biomarkers of the iron status in human serum and plasma. |
Q92170714 | Low frataxin mRNA expression is associated with inflammation and oxidative stress in patients with type 2 diabetes |
Q51552053 | Low hemoglobin density potential marker of iron availability. |
Q33853010 | Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study |
Q38431492 | Low transferrin saturation is associated with impaired fasting glucose and insulin resistance in the South Korean adults: the 2010 Korean National Health and Nutrition Examination Survey |
Q50060591 | Management of Anemia in Patients with Inflammatory Bowel Disease (IBD). |
Q47821861 | Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice. |
Q42766145 | Markers of iron metabolism in retired racing Greyhounds with and without osteosarcoma |
Q38887263 | Markers of iron status in chronic kidney disease |
Q52581674 | Measurement of iron status in chronic kidney disease. |
Q43677689 | Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease |
Q36450638 | Mechanism of anemia in Schistosoma mansoni-infected school children in Western Kenya |
Q37563605 | Metals in the pathogenesis of type 2 diabetes |
Q92462134 | Monitoring of iron status in patients with heart failure |
Q57191817 | Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach |
Q37893439 | Pattern of resistance to erythropoietin-stimulating agents in chronic kidney disease |
Q39002211 | Patterns and determinants of functional and absolute iron deficiency in patients undergoing cardiac rehabilitation following heart surgery |
Q50240951 | Percentage of hypochromic erythrocytes and reticulocyte hemoglobin equivalent predictors of response to intravenous iron in hemodialysis patients |
Q47348851 | Physical exercise intervention at school improved hepcidin, inflammation, and iron metabolism in overweight and obese children and adolescents. |
Q51066665 | Plasma neutrophil gelatinase-associated lipocalin is associated with iron status in anemic patients with pre-dialysis chronic kidney disease. |
Q47129994 | Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease |
Q46049718 | Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis |
Q33720452 | Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: The PrEP Registry |
Q27004170 | Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron |
Q36950488 | Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia |
Q34785164 | Prohepcidin levels in refractory anaemia caused by lead poisoning |
Q64093853 | Red Blood Cell Variables in Children and Adolescents regarding the Age and Sex |
Q35665003 | Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure |
Q98613424 | Relationship between iron status markers and insulin resistance: an exploratory study in subjects with excess body weight |
Q47835950 | Relationships between iron dose, hospitalizations and mortality in incident haemodialysis patients: a propensity-score matched approach. |
Q35694046 | Resistance of dialyzed patients to erythropoietin |
Q50913758 | Retrospective study of reticulocyte indices as indicators of iron-restricted erythropoiesis in dogs with immune-mediated hemolytic anemia. |
Q61818280 | Role of Soluble Transferrin Receptor and Transferrin Receptor-Ferritin Index to Detect Iron Deficiency Anemia in Regular Hemodialysis Patients |
Q37161960 | Safety issues with intravenous iron products in the management of anemia in chronic kidney disease |
Q24626621 | Serum ferritin: Past, present and future |
Q37647139 | Soluble transferrin receptor-ferritin index in the evaluation of anemia in inflammatory bowel disease: a case-control study |
Q64103057 | Studying anemia of chronic disease and iron deficiency in patients with rheumatoid arthritis by iron status and circulating hepcidin |
Q90618470 | T2 ∗ Relaxation Time Obtained from Magnetic Resonance Imaging of the Liver Is a Useful Parameter for Use in the Construction of a Murine Model of Iron Overload |
Q37631132 | The Effects of Nutrition, Exercise, and a Praying Program on Reducing Iron Overload in Patients With Beta-Thalassemia Major: A Randomized Clinical Trial. |
Q90024553 | The Effects of Psychological and Environmental Stress on Micronutrient Concentrations in the Body: A Review of the Evidence |
Q37668885 | The FIND-CKD study--a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale |
Q92959917 | The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia |
Q47793807 | The Role of Iron in Type 1 Diabetes Etiology: A Systematic Review of New Evidence on a Long-Standing Mystery |
Q37542851 | The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients |
Q35088131 | The relationship of initial transferrin saturation to cardiovascular parameters and outcomes in patients initiating dialysis |
Q37405665 | The transplant iron score as a predictor of stem cell transplant survival |
Q46801018 | The utility of reticulocyte indices in distinguishing iron deficiency anemia from anemia of inflammatory disease, portosystemic shunting, and breed-associated microcytosis in dogs |
Q93159789 | The validity of reticulocyte hemoglobin content and percentage of hypochromic red blood cells for screening iron-deficiency anemia among patients with end-stage renal disease: a retrospective analysis |
Q35130666 | Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells |
Q35996211 | Understanding renal posttransplantation anemia in the pediatric population |
Q57040818 | Utility of reticulocyte haemoglobin content and percentage hypochromic red cells as markers of iron deficiency anaemia among black CKD patients in South Africa |
Q53102532 | Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS). |
Search more.